San Diego, CA, United States of America

Kumar Srinivasan

This inventor holds 5 USPTO granted patents. Top assignees: Genta Incorporated, Promega Biosciences, Inc.. Active years: 1999-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kumar Srinivasan. Retrieved from https://idiyas.com/inventor/kumar-srinivasan-81jq0jd3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 80.0

Average Co-Inventor Count = 5.0

ph-index = 5

Forward Citations = 229(Granted Patents)


Company Filing History:


Years Active: 1999-2003

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Kumar Srinivasan

Introduction

Kumar Srinivasan is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly through his innovative work on amide-based cationic lipids. With a total of 5 patents to his name, his inventions have the potential to impact various applications in medicine and research.

Latest Patents

One of Kumar's latest patents focuses on amide-based cationic lipids. This innovation is crucial for developing new drug delivery systems and enhancing the efficacy of therapeutic agents. His work in this area demonstrates his commitment to advancing biotechnological solutions.

Career Highlights

Throughout his career, Kumar has worked with prominent companies such as Genta Incorporated and Promega Biosciences, Inc. These experiences have allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Kumar has had the opportunity to work alongside talented individuals, including David Aaron Schwartz and Brian Patrick Dwyer. These collaborations have enriched his research and fostered a creative environment for innovation.

Conclusion

Kumar Srinivasan's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to inspire advancements in drug delivery and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…